Bausch Health Companies Inc [BHC] stock is trading at $7.18, down -1.91%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The BHC shares have gain 5.28% over the last week, with a monthly amount glided 17.51%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Bausch Health Companies Inc [NYSE: BHC] stock has seen the most recent analyst activity on December 09, 2025, when Barclays initiated its Equal Weight rating and assigned the stock a price target of $8. Previously, Piper Sandler downgraded its rating to Underweight on August 02, 2024, and dropped its price target to $3. On July 10, 2024, Raymond James initiated with a Mkt Perform rating and assigned a price target of $8 on the stock. Jefferies upgraded its rating to a Buy and increased its price target to $16 on September 20, 2023. TD Cowen downgraded its rating to a Market Perform. Truist downgraded its rating to Hold for this stock on July 29, 2022. In a note dated July 29, 2022, RBC Capital Mkts downgraded an Sector Perform rating on this stock and revised its target price from $12 to $5.
Bausch Health Companies Inc [BHC] stock has fluctuated between $4.25 and $8.69 over the past year. Currently, Wall Street analysts expect the stock to reach $8 within the next 12 months. Bausch Health Companies Inc [NYSE: BHC] shares were valued at $7.18 at the most recent close of the market. An investor can expect a potential return of 11.42% based on the average BHC price forecast.
Analyzing the BHC fundamentals
Bausch Health Companies Inc [NYSE:BHC] reported sales of 10.03B for the trailing twelve months, which represents a growth of 6.81%. Gross Profit Margin for this corporation currently stands at 0.82% with Operating Profit Margin at 0.23%, Pretax Profit Margin comes in at 0.06%, and Net Profit Margin reading is 0.04%. To continue investigating profitability, this company’s Return on Assets is posted at 0.01, Equity is -0.38 and Total Capital is 0.09. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of-37.21.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 7.11 points at the first support level, and at 7.03 for the second support level. However, for the 1st resistance point, the stock is sitting at 7.30, and for the 2nd resistance point, it is at 7.41.
Ratios To Look Out For
For context, Bausch Health Companies Inc’s Current Ratio is 1.30. In addition, the Quick Ratio stands at 0.97 and the Cash Ratio stands at 0.27. Considering the valuation of this stock, the price to sales ratio is 0.27 and price to earnings (TTM) ratio is 7.41.
Transactions by insiders
Recent insider trading involved PAULSON & CO. INC., 10% Owner, that happened on Nov 25 ’25 when 2.5 million shares were purchased. EVP, General Counsel, Carson Seana completed a deal on Sep 08 ’25 to sell 13370.0 shares. Meanwhile, Officer Carson Seana bought 13370.0 shares on Sep 08 ’25.
